Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome

Objectives: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in infertile women characterized by both reproductive and metabolic dysfunctions of different degrees. Furthermore, it has been associated with increased cardiovascular disease (CVD) risk and related long-term health sequ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Murat Gözüküçük, Aslı Yarcı Gürsoy, Emre Destegül, Salih Taşkİn, Hakan Şatıroğlu
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer Medknow Publications 2021
Materias:
Acceso en línea:https://doaj.org/article/19e260343d6646d3937cfdde1af57397
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:19e260343d6646d3937cfdde1af57397
record_format dspace
spelling oai:doaj.org-article:19e260343d6646d3937cfdde1af573972021-11-12T10:10:38ZHomocysteine and C-reactive protein levels in women with polycystic ovary syndrome2213-307010.4103/GMIT.GMIT_30_20https://doaj.org/article/19e260343d6646d3937cfdde1af573972021-01-01T00:00:00Zhttp://www.e-gmit.com/article.asp?issn=2213-3070;year=2021;volume=10;issue=4;spage=210;epage=214;aulast=Gözüküçükhttps://doaj.org/toc/2213-3070Objectives: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in infertile women characterized by both reproductive and metabolic dysfunctions of different degrees. Furthermore, it has been associated with increased cardiovascular disease (CVD) risk and related long-term health sequela. The aim of this study is to evaluate serum homocysteine (Hcy) and C-reactive protein (CRP) levels in women with PCOS and to evaluate their relationship with clinical and laboratory parameters in women with PCOS.Materials and Methods: The prospective single-center study included 45 women with PCOS (study group) and 41 control subjects. Demographic variables and Hcy, CRP, fasting blood glucose, insulin, follicle-stimulating hormone, luteinizing hormone, estradiol, total and free testosterone, dehydroepiandrosterone sulfate, thyroid-stimulating hormone levels, and lipid profiles of the subjects were recorded. homeostatic model assessment for insulin resistance (HOMA-IR) indexes were calculated.Results: Fasting plasma glucose, insulin, HOMA-IR, free and total testosterone levels, and clinical hirsutism were significantly higher in the study group. There was no statistically significant difference in lipid profile between groups. Hcy and CRP levels were higher in the study group, which was not statistically significantly different (P > 0.05).Conclusion: Some of the parameters that are correlated with CVD risk were found to be higher in women with PCOS, although the difference for Hcy and CRP did not reach statistical significance. However, the current study reveals that the CVD risk associated with PCOS deserves more comprehensive prospective studies with long-term outcomes.Murat GözüküçükAslı Yarcı GürsoyEmre DestegülSalih TaşkİnHakan ŞatıroğluWolters Kluwer Medknow Publicationsarticlec-reactive proteinhomocysteinepolycystic ovary syndromeGynecology and obstetricsRG1-991ENGynecology and Minimally Invasive Therapy, Vol 10, Iss 4, Pp 210-214 (2021)
institution DOAJ
collection DOAJ
language EN
topic c-reactive protein
homocysteine
polycystic ovary syndrome
Gynecology and obstetrics
RG1-991
spellingShingle c-reactive protein
homocysteine
polycystic ovary syndrome
Gynecology and obstetrics
RG1-991
Murat Gözüküçük
Aslı Yarcı Gürsoy
Emre Destegül
Salih Taşkİn
Hakan Şatıroğlu
Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome
description Objectives: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in infertile women characterized by both reproductive and metabolic dysfunctions of different degrees. Furthermore, it has been associated with increased cardiovascular disease (CVD) risk and related long-term health sequela. The aim of this study is to evaluate serum homocysteine (Hcy) and C-reactive protein (CRP) levels in women with PCOS and to evaluate their relationship with clinical and laboratory parameters in women with PCOS.Materials and Methods: The prospective single-center study included 45 women with PCOS (study group) and 41 control subjects. Demographic variables and Hcy, CRP, fasting blood glucose, insulin, follicle-stimulating hormone, luteinizing hormone, estradiol, total and free testosterone, dehydroepiandrosterone sulfate, thyroid-stimulating hormone levels, and lipid profiles of the subjects were recorded. homeostatic model assessment for insulin resistance (HOMA-IR) indexes were calculated.Results: Fasting plasma glucose, insulin, HOMA-IR, free and total testosterone levels, and clinical hirsutism were significantly higher in the study group. There was no statistically significant difference in lipid profile between groups. Hcy and CRP levels were higher in the study group, which was not statistically significantly different (P > 0.05).Conclusion: Some of the parameters that are correlated with CVD risk were found to be higher in women with PCOS, although the difference for Hcy and CRP did not reach statistical significance. However, the current study reveals that the CVD risk associated with PCOS deserves more comprehensive prospective studies with long-term outcomes.
format article
author Murat Gözüküçük
Aslı Yarcı Gürsoy
Emre Destegül
Salih Taşkİn
Hakan Şatıroğlu
author_facet Murat Gözüküçük
Aslı Yarcı Gürsoy
Emre Destegül
Salih Taşkİn
Hakan Şatıroğlu
author_sort Murat Gözüküçük
title Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome
title_short Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome
title_full Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome
title_fullStr Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome
title_full_unstemmed Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome
title_sort homocysteine and c-reactive protein levels in women with polycystic ovary syndrome
publisher Wolters Kluwer Medknow Publications
publishDate 2021
url https://doaj.org/article/19e260343d6646d3937cfdde1af57397
work_keys_str_mv AT muratgozukucuk homocysteineandcreactiveproteinlevelsinwomenwithpolycysticovarysyndrome
AT aslıyarcıgursoy homocysteineandcreactiveproteinlevelsinwomenwithpolycysticovarysyndrome
AT emredestegul homocysteineandcreactiveproteinlevelsinwomenwithpolycysticovarysyndrome
AT salihtaskin homocysteineandcreactiveproteinlevelsinwomenwithpolycysticovarysyndrome
AT hakansatıroglu homocysteineandcreactiveproteinlevelsinwomenwithpolycysticovarysyndrome
_version_ 1718430974722703360